M&A

Roche will acquire the California-based diagnostics company for $1.8 billion

CELLINK to expand testing offerings with acquisition of MatTek

Thermo Fisher has completed the acquisition of Mesa Biotech and its Accula System PCR testing platform

Horizon to acquire Viela Bio for $3.05B

The collaboration will develop and apply deep learning and machine learning for drug discovery

Move will expand Chimerix pipeline with late-stage oncology program

Acquisition will expand Thermo Fisher’s global capacity for cell and gene therapies

Distributed Bio adds large-molecule discovery platform to Charles River's repertoire

The deal nets Servier a clinical oncology portfolio and will expand its U.S. footprint

The acquisition nets Merck a pipeline of oncology programs as well as CD24Fc, OncoImmune's lead candidate for the treatment of COVID-19